Obstructive Lung Diseases |

Accuracy of Continuous Noninvasive Respiratory Rate Derived From Pulse Oximetry in Chronic Obstructive Pulmonary Disease Patients FREE TO VIEW

Michael Mestek, PhD; Paul Addison, PhD; Anna-Maria Neitenbach, MD; Sergio Bergese*, MD; Scott Kelley, MD
Author and Funding Information

Covidien, Boulder, CO

Chest. 2012;142(4_MeetingAbstracts):671A. doi:10.1378/chest.1390308
Text Size: A A A
Published online



PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM

PURPOSE: A new method of analyzing a pulse oximeter waveform (RRoxi algorithm) allows continuous non-invasive respiratory rate monitoring. The RRoxi algorithm uses respiratory-induced modulations in the photoplethysmogram secondary to changes in hemodynamic and autonomic activity throughout the respiratory cycle. Patients with chronic obstructive pulmonary disease (COPD) may exhibit abnormal cardiorespiratory interactions that could influence the modulations used by RRoxi to extract respiratory rate. We therefore sought to determine the accuracy of RRoxi in patients with COPD.

METHODS: With IRB approval and patient consent, we enrolled 22 non-intubated patients diagnosed with COPD (age: 61.8 ± 11.8 yr; BMI: 28.6 ± 7.7 kg/m2, 4 female/ 18 male). During an observational study period of ~20 min on the general care floor or in the ICU, photoplethysmogram data were acquired from an index finger using a pulse oximetry sensor. Nasal/oral capnography waveforms were acquired simultaneously to determine a reference respiratory rate. Respiratory rate values were computed offline by RRoxi. Accuracy was calculated as root mean square deviation (RMSD) between RRoxi and the reference respiratory rate, and Pearson correlation coefficients were computed to assess their relationship.

RESULTS: RRoxi determined a respiratory rate value 93% of the monitoring period, yielding a total of 4,917 paired observations (RRoxi values and the capnography-based reference). Mean and range of the reference respiratory rate were 17.6 ± 4.4 and 8.1 to 32 breaths per minute, respectively. The mean difference between the reference and RRoxi respiratory rate measurements was 0.7 ± 1.6 breaths per minute. The accuracy of RRoxi was 1.7 breaths per minute, as measured by RMSD and the agreement between RRoxi and the reference was R2=0.87.

CONCLUSIONS: These results demonstrate that in patients with COPD, the RRoxi algorithm was accurate to within 1.7 breaths per minute (RMSD) and able to determine a respiratory rate value during 93% of the monitoring period.

CLINICAL IMPLICATIONS: These accuracy and availability results suggest that RRoxi should be clinically acceptable to provide continuous non-invasive respiratory rate monitoring in similar hospitalized patients.

DISCLOSURE: Michael Mestek: Employee: Covidien Respiratory & Monitoring Solutions Scientist

Paul Addison: Employee: Covidien Respiratory & Monitoring Solutions Scientist

Anna-Maria Neitenbach: Employee: Covidien Respiratory & Monitoring Solutions Research Associate.

Sergio Bergese: Other: Dr. Bergese received financial funding for data collection on hospitalized patients for this study.

Scott Kelley: Employee: Dr. Kelley is the Chief Medical Officer at Covidien Respiratory & Monitoring Solutions

No Product/Research Disclosure Information

Covidien, Boulder, CO




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543